SoftBank-Backed Guardant Soars in Trading Debut After U.S. IPO

Bookmark
(Bloomberg) -- Guardant Health Inc., a cancer-detection firm backed by SoftBank Group Corp., climbed in its trading debut after raising $237.5 million in its U.S. initial public offering.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.